Safrel Pharmaceuticals LLC Warning Letter Details
Warning LetterSafrel Pharmaceuticals LLC
Issue DateAugust 07, 2026
FEI NumberN/A
Violations3
CountryN/A
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
OpenSubject
CGMP/Finished Pharmaceuticals/Adulterated